Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -35,625 | -130,904 | -102,758 |
| Depreciation Amortization | -734 | -114 | 204 |
| Accounts payable and accrued liabilities | -6,012 | N/A | 1,863 |
| Other Working Capital | 309 | -6,948 | -1,771 |
| Other Operating Activity | 9,021 | 23,070 | 17,932 |
| Operating Cash Flow | $-33,041 | $-114,896 | $-84,530 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -36 | -511 | -488 |
| Purchase Of Investment | -41,483 | N/A | -178,274 |
| Sale Of Investment | 44,336 | N/A | 31,779 |
| Other Investing Activity | 0 | -167,502 | -13,000 |
| Investing Cash Flow | $2,817 | $-168,013 | $-159,983 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 602 | N/A | 2,616 |
| Common Stock Repurchased | -491 | N/A | N/A |
| Other Financing Activity | -10 | 115,743 | 86,294 |
| Financing Cash Flow | $101 | $115,743 | $88,910 |
| Beginning Cash Position | 242,206 | 409,372 | 409,372 |
| End Cash Position | 212,083 | 242,206 | 253,769 |
| Net Cash Flow | $-30,123 | $-167,166 | $-155,603 |
| Free Cash Flow | |||
| Operating Cash Flow | -33,041 | -114,896 | -84,530 |
| Capital Expenditure | -36 | N/A | -488 |
| Free Cash Flow | -33,077 | -114,896 | -85,018 |